Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2026 Filed Aug 31, 2026 21:21 UTC |
Allaire Bella LoykhterChief Admin Officer
|
SaleCommon Stock | 7,500 | $177.60 | $1,331,981.25 |
DisclosureSEC source: 0001225208-26-007407 · doc4.xml · nonDerivative · entry 1 Allaire Bella Loykhter · CIK 0001537767 · Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,086 F1 · kind: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: Reflects the weighted average sale price. The range of prices for such transaction was $177.58 to $177.59. Read SEC document |
| August 20, 2026 Filed Aug 27, 2026 18:14 UTC |
Helal TarekChief Strategy Officer
|
GiftCommon Stock | 23,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-007342 · doc4.xml · nonDerivative · entry 2 Helal Tarek · CIK 0001886423 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,140 F1 · balance_after: Includes 54 shares of common stock acquired on March 3, 2026 and 57 shares of common stock acquired on June 2, 2026 pursuant to the registrant's Employee Stock Purchase Plan. Read SEC document |
| August 20, 2026 Filed Aug 27, 2026 18:14 UTC |
Helal TarekChief Strategy Officer
|
GiftCommon Stock | 23,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-007342 · doc4.xml · nonDerivative · entry 1 Helal Tarek · CIK 0001886423 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,537 F1 · balance_after: Includes 54 shares of common stock acquired on March 3, 2026 and 57 shares of common stock acquired on June 2, 2026 pursuant to the registrant's Employee Stock Purchase Plan. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 12:50 UTC |
Curtis Scott AChief Operating Officer
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-007224 · doc4.xml · nonDerivative · entry 1 Curtis Scott A · CIK 0001601143 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,418 Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 18:49 UTC |
Elwyn Tashtego SPresident, PCG
|
SaleCommon Stock | 10,000 | $176.06 | $1,760,552.00 |
DisclosureSEC source: 0001225208-26-006781 · doc4.xml · nonDerivative · entry 1 Elwyn Tashtego S · CIK 0001601145 · President, PCG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,114 F1 · kind: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: Reflects the weighted average sale price. The range of prices for such transaction was $176.00 to $176.17. Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 20:35 UTC |
Raney Steven MExecutive Chair RJBank
|
SaleCommon Stock | 5,770 | $172.97 | $998,032.86 |
DisclosureSEC source: 0001225208-26-006757 · doc4.xml · nonDerivative · entry 1 Raney Steven M · CIK 0001422342 · Executive Chair RJBank 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,046 F1 · kind: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: Reflects the weighted average sale price. The range of prices for such transaction was $172.83 to $173.13. F3 · balance_after: Includes 40 shares of common stock acquired on March 3, 2026 and 43 shares of common stock acquired on June 2, 2026 pursuant to the registrant's Employee Stock Purchase Plan. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 19:00 UTC |
Allaire Bella LoykhterChief Admin Officer
|
SaleCommon Stock | 29,551 | $142.34 | $4,206,289.34 |
DisclosureSEC source: 0001225208-26-003890 · doc4.xml · nonDerivative · entry 1 Allaire Bella Loykhter · CIK 0001537767 · Chief Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,586 F1 · kind: The reporting person contributed the registrant's common stock to an exchange fund in exchange for shares of the exchange fund. The registrant's common stock was valued at $142.34 per share for purposes of determining the number of shares of the exchange fund issuable to the reporting person. F1 · price: The reporting person contributed the registrant's common stock to an exchange fund in exchange for shares of the exchange fund. The registrant's common stock was valued at $142.34 per share for purposes of determining the number of shares of the exchange fund issuable to the reporting person. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 19:12 UTC |
Aisenbrey Christopher SChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002940 · doc4.xml · derivative · entry 4 Aisenbrey Christopher S · CIK 0001913663 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: RSUs vested 60% on 2/28/2025, 20% on 2/28/2026, and will vest 20% on 2/28/2027. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 19:12 UTC |
Aisenbrey Christopher SChief Human Resources Officer
|
Tax withholdingCommon Stock | 132 | $153.08 | $20,206.56 |
DisclosureSEC source: 0001225208-26-002940 · doc4.xml · nonDerivative · entry 2 Aisenbrey Christopher S · CIK 0001913663 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,490 Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 19:12 UTC |
Aisenbrey Christopher SChief Human Resources Officer
|
Exercise / conversionCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002940 · doc4.xml · nonDerivative · entry 1 Aisenbrey Christopher S · CIK 0001913663 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:54 UTC |
Edwards Jeffrey NDirector
|
GiftCommon Stock | 1,503.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002653 · doc4.xml · nonDerivative · entry 2 Edwards Jeffrey N · CIK 0001293146 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 22,008 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:54 UTC |
Edwards Jeffrey NDirector
|
GiftCommon Stock | 1,503.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002653 · doc4.xml · nonDerivative · entry 1 Edwards Jeffrey N · CIK 0001293146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,533 Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:58 UTC |
Seshadri RajDirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002385 · doc4.xml · nonDerivative · entry 1 Seshadri Raj · CIK 0001772738 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,782 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the fifth anniversary of the vest date. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:56 UTC |
MCDANIEL RAYMOND WDirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002384 · doc4.xml · nonDerivative · entry 1 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,113 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:54 UTC |
MCGEARY RODERICK CDirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002383 · doc4.xml · nonDerivative · entry 1 MCGEARY RODERICK C · CIK 0001206884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,354 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the third anniversary of the vest date. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:52 UTC |
Gates AnneDirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002382 · doc4.xml · nonDerivative · entry 1 Gates Anne · CIK 0001660111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,848 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the fifth anniversary of the vest date. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:49 UTC |
GARCIA ART ADirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002381 · doc4.xml · nonDerivative · entry 1 GARCIA ART A · CIK 0001183585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,992 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:48 UTC |
Esty BenjaminDirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002380 · doc4.xml · nonDerivative · entry 1 Esty Benjamin · CIK 0001325337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,794 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · derivative · entry 9 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 496 Underlying: Common Stock · 1,253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F5 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F5 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · derivative · entry 8 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,749 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F5 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F5 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · derivative · entry 7 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,999 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F5 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F5 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
GrantRestricted Stock Units · Derivative | 248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · derivative · entry 6 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,249 Underlying: Common Stock · 248 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F4 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. F4 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
GrantRestricted Stock Units · Derivative | 248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · derivative · entry 5 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,001 Underlying: Common Stock · 248 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F4 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. F4 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · nonDerivative · entry 4 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · nonDerivative · entry 3 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
Exercise / conversionCommon Stock | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · nonDerivative · entry 2 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:46 UTC |
Mistarz CecilyDirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002379 · doc4.xml · nonDerivative · entry 1 Mistarz Cecily · CIK 0002021190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,489 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the second anniversary of the vest date. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:39 UTC |
Edwards Jeffrey NDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002378 · doc4.xml · derivative · entry 4 Edwards Jeffrey N · CIK 0001293146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,303 Underlying: Common Stock · 1,253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F3 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:39 UTC |
Edwards Jeffrey NDirector
|
GrantRestricted Stock Units · Derivative | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002378 · doc4.xml · derivative · entry 3 Edwards Jeffrey N · CIK 0001293146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,556 Underlying: Common Stock · 1,303 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:39 UTC |
Edwards Jeffrey NDirector
|
Exercise / conversionCommon Stock | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002378 · doc4.xml · nonDerivative · entry 1 Edwards Jeffrey N · CIK 0001293146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,036.5 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:36 UTC |
DEBEL MARLENEDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002377 · doc4.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,303 Underlying: Common Stock · 1,253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F3 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:36 UTC |
DEBEL MARLENEDirector
|
GrantRestricted Stock Units · Derivative | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002377 · doc4.xml · derivative · entry 2 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,556 Underlying: Common Stock · 1,303 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:36 UTC |
DEBEL MARLENEDirector
|
Exercise / conversionCommon Stock | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002377 · doc4.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:28 UTC |
Begor Mark WDirector
|
GrantCommon Stock | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002376 · doc4.xml · nonDerivative · entry 1 Begor Mark W · CIK 0001335111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,285 F1 · shares: Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors. F2 · balance_after: Includes DRSUs. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 21:30 UTC |
Santelli Jonathan NEVP, General Counsel
|
SaleCommon Stock | 4,500 | $170.46 | $767,079.00 |
DisclosureSEC source: 0001225208-26-001359 · doc4.xml · nonDerivative · entry 1 Santelli Jonathan N · CIK 0001672865 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,853 Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 18:59 UTC |
Edwards Jeffrey NDirector
|
GiftCommon Stock | 20,504.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001141 · doc4.xml · nonDerivative · entry 2 Edwards Jeffrey N · CIK 0001293146 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 20,504.5 Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 18:59 UTC |
Edwards Jeffrey NDirector
|
GiftCommon Stock | 20,504.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001141 · doc4.xml · nonDerivative · entry 1 Edwards Jeffrey N · CIK 0001293146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,783.5 Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 15:39 UTC |
Helal TarekChief Strategy Officer
|
GiftCommon Stock | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000002 · doc4.xml · nonDerivative · entry 3 Helal Tarek · CIK 0001886423 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By the Tarek Helal 2021 Gifting Trust Disclosed balance after: 81 Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 15:39 UTC |
Helal TarekChief Strategy Officer
|
GiftCommon Stock | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000002 · doc4.xml · nonDerivative · entry 2 Helal Tarek · CIK 0001886423 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By the Mohamed Anis Helal March 2022 GRAT #4 Disclosed balance after: 0 Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 15:39 UTC |
Helal TarekChief Strategy Officer
|
GiftCommon Stock | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000002 · doc4.xml · nonDerivative · entry 1 Helal Tarek · CIK 0001886423 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By the Mohamed Anis Helal March 2022 GRAT #4 Disclosed balance after: 81 Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
GrantRestricted Stock Units · Derivative | 20,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · derivative · entry 17 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,751 Underlying: Common Stock · 20,751 shares Expires 2028-12-15 F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F9 · shares: Award of RSUs as a portion of annual bonus under Amended and Restated 2012 Stock Incentive Plan. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
Exercise / conversionRestricted Stock Units · Derivative | 54,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · derivative · entry 16 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,406 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
Exercise / conversionRestricted Stock Units · Derivative | 30,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · derivative · entry 15 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,406 Underlying: Common Stock · 30,853 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
Exercise / conversionRestricted Stock Units · Derivative | 7,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · derivative · entry 14 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,715 Underlying: Common Stock · 7,073 shares Expires 2027-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F8 · derivative.exercise_date: RSUs vested 60% on 12/15/2025 and will vest 20% on 12/15/2026 and 20% on 12/15/2027. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
SaleCommon Stock | 56,757 | $162.69 | $9,233,512.55 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · nonDerivative · entry 12 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,546 F2 · kind: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Mr. Reilly, age 71, is effecting the sales reported herein as part of a comprehensive diversification and estate planning process. By annually selling shares as his RSUs vest during recent years, he has consistently maintained a stable net position in Raymond James Financial, Inc. (RJF) common stock. Following these sales, Mr. Reilly's stock ownership will likewise remain at approximately the same level. Consistent with his strong confidence in the company and its senior management, Mr. Reilly currently intends to maintain approximately the same level of ownership for as long as he serves on the Board, which level is also significantly in excess of applicable requirements under the company's Director and Executive Officer Stock Ownership Policy. F6 · price: Reflects the weighted average sale price. The range of prices for such transaction was $161.96 to $162.95 Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
SaleCommon Stock | 53,660 | $163.24 | $8,759,254.49 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · nonDerivative · entry 11 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,303 F2 · kind: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Mr. Reilly, age 71, is effecting the sales reported herein as part of a comprehensive diversification and estate planning process. By annually selling shares as his RSUs vest during recent years, he has consistently maintained a stable net position in Raymond James Financial, Inc. (RJF) common stock. Following these sales, Mr. Reilly's stock ownership will likewise remain at approximately the same level. Consistent with his strong confidence in the company and its senior management, Mr. Reilly currently intends to maintain approximately the same level of ownership for as long as he serves on the Board, which level is also significantly in excess of applicable requirements under the company's Director and Executive Officer Stock Ownership Policy. F5 · price: Reflects the weighted average sale price. The range of prices for such transaction was $162.96 to $163.95. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
Tax withholdingCommon Stock | 39,616 | $163.85 | $6,491,081.60 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · nonDerivative · entry 10 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,963 Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
GiftCommon Stock | 30,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · nonDerivative · entry 9 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,579 Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
Tax withholdingCommon Stock | 22,466 | $163.85 | $3,681,054.10 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · nonDerivative · entry 8 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,095 Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 01:04 UTC |
REILLY PAUL CDirector · Executive Chair
|
Tax withholdingCommon Stock | 20,399 | $163.85 | $3,342,376.15 |
DisclosureSEC source: 0001225208-25-010012 · doc4.xml · nonDerivative · entry 7 REILLY PAUL C · CIK 0001240439 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,561 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.